Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-669899f699-ggqkh Total loading time: 0 Render date: 2025-05-04T05:00:33.873Z Has data issue: false hasContentIssue false

6 - Emerging viruses in transfusion

from Section 1 - Agents

Published online by Cambridge University Press:  12 January 2010

By
Jean-Pierre Allain  and
John A. J. Barbara
Edited by
John A. J. Barbara ,
Fiona A. M. Regan  and
Marcela Contreras
Jean-Pierre Allain
Affiliation:
Department of Haematology, The Division of Transfusion Medicine, Cambridge Blood Centre, Cambridge, UK
John A. J. Barbara
Affiliation:
Emeritus Consultant in Microbiology to NHS Blood and Transplant and Visiting Professor in Transfusion Microbiology, University of the West of England, Bristol, UK
John A. J. Barbara
Affiliation:
University of the West of England, Bristol
Fiona A. M. Regan
Affiliation:
HNSBT and Hammersmith Hospitals NHS Trust, London
Marcela Contreras
Affiliation:
University of the West of England, Bristol
Get access

Summary

Introduction

The availability of a broad range of molecular biological techniques following the development of polymerase chain reaction (PCR) had a major impact on the discovery of new viruses, often outside the classical context of a clinical disease. Conversely, the same techniques were used to examine diseases of unknown aetiology where a viral involvement was suspected and a virus was identified, long, controversial, and often inconclusive data were assembled by investigators to demonstrate the connection between this viral agent and the original disease such as human herpes virus 8 (HHV-8) in multiple myeloma. Besides the virological issues, in such circumstances, relevance to transfusion was invariably examined, irrespective of pathogenicity (Allain, 2000).

In the past ten years, several extra- and intra-cellular viruses have been discovered or re-discovered and only one, West Nile virus (WNV), led to blood screening, the other viruses are at the present time considered not worthy of screening due to lack of pathogenicity (GBV-C/HGV, TTV, SEN-V) and/or high prevalence (TTV, SEN-V), or lack of evidence of transfusion-transmissibility despite clear pathogenicity, for example HHV-8. Another issue explaining the reluctance to screen was that most viruses needed genomic amplification methods for detection (please refer to Chapter 14) and this added substantially to the complication and costs of current procedures for blood testing (Allain et al., 2002).

Despite these limitations of scope and practicality, it is important in the context of transfusion microbiology to be aware of these viruses whose features and pathogenicity can be better understood in the future, and this may influence future policy.

Type
Chapter
Information
Transfusion Microbiology , pp. 75 - 86
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Chutinimiktul, A., Bhattarakosol, P., Srisuratanon, S., et al. (2006) H5N1 influenza A virus and infected human plasma. Emerging Infectious Diseases, 12, 1041–3.CrossRefGoogle Scholar
Lehmann, N. I. and Gust, D. (1971 Viraemia in influenza. A report of two cases. Med J Aust, 2; 1166–9).Google ScholarPubMed
Naficy, K. (1963) Human influenza infection with proved viremia: report of a case. N Engl J Med, 269, 964–6.CrossRefGoogle ScholarPubMed
Pfeiffer, J. K. and Kirkegaard K. (2005) Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice. PLoS Pathog, 1(2): e11.CrossRef
Allain, J.-P. (2000) Emerging viral infections relevant to transfusion medicine. Blood Rev, 14, 173–81.CrossRefGoogle ScholarPubMed
Allain, J.-P., Thomas, I. and Sauleda, S. (2002) Nucleic acid testing for emerging viral infections. Transfusion Medicine, 12, 275–83.CrossRefGoogle ScholarPubMed
Alter, H. J., Nakatsuji, Y., Melpolder, J., et al. (1997) The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Eng J Med, 336, 747–54.CrossRefGoogle ScholarPubMed
Anonymous (2002a) Provisional surveillance summary of the West Nile virus epidemic – United States, January–November 2002. MMWR, 51, 1129–33.
Anonymous (2002b) Public health dispatch: investigation of West Nile virus infection in recipients of blood transfusion. MMWR, 51, 973–4.
Anonymous (2003) Detection of West Nile virus in blood donations – United States, 2003. MMWR, 52, 769–72.
Belec, L., Si Mohammed, A., Authier, F. J., et al. (1999) Human herpes virus 8 infection with POEMS syndrome-associated multicentric Castleman's disease. Blood, 93, 3643–53.Google Scholar
Bjorkman, P., Naucler, A., Winqvist, N., et al. (2001) A case-control study of transmission routes for GB virus C/hepatitis G virus in Swedish blood donors lacking markers for hepatitis C virus infection. Vox Sang, 81, 148–53.CrossRefGoogle ScholarPubMed
Blackbourn, D. J., Ambroziak, J., Lennette, E., et al. (1997) Infectious human herpes virus 8 in a healthy North American blood donor. Lancet, 349, 609–11.CrossRefGoogle Scholar
Boschoff, C. and Weiss, R. A. (1998) Kaposi's sarcoma-associated herpes virus. Adv Cancer Res, 75, 57–86.CrossRefGoogle Scholar
Brayfield, B. P., Phiri, S., Kankasa, C., et al. (2003) Postnatal human herpes virus 8 and human immunodeficiency virus type 1 infection in mothers and infants from Zambia. J Inf Dis, 187, 559–68.CrossRefGoogle ScholarPubMed
Brinton, M. A. (2002) The molecular biology of West Nile virus: a new invader of the Western hemisphere. Ann Rev Microbiol, 56, 371–402.CrossRefGoogle ScholarPubMed
Campbell, G. L., Ceianu, C. S. and Savage, H. M. (2001) Epidemic West Nile encephalitis in Romania: waiting for history to repeat itself. Ann NY Acad Sci, 951, 94–101.CrossRefGoogle Scholar
Campbell, G. L., Martin, A. A., Lanciotti, R. S., et al. (2002) West Nile virus. Lancet Infect Dis, 2, 519–29.CrossRefGoogle ScholarPubMed
Cannon, M. J., Dollard, S. C., Smith, D. K., et al. (2001) Blood-borne and sexual transmission of human herpes virus 8 in women with or at risk for human immunodeficiency virus infection. N Eng J Med, 344, 637–43.CrossRefGoogle ScholarPubMed
Cattani, P., Nanni, G., Graffeo, R., et al. (2000) Pretransplantation human herpes virus 8 seropositivity as a risk factor for Kaposi's sarcoma in kidney transplant recipients. Transplant Proc, 32, 526–7.CrossRefGoogle ScholarPubMed
Chowers, M. Y., Lang, R., Nassar, F., et al. (2000) Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infec Dis, 7, 1–9.Google Scholar
Devalle, S. and Niel, C. (2004) Distribution of TT virus genomic groups 1–5 in Brazilian blood donors, HBV carriers, and HIV-1-infected patients. J Med Virol, 72, 166–73.CrossRefGoogle ScholarPubMed
Fan, X., Xu, Y., Detre, K,et al. (2002) Direct evidence for GB virus C/hepatitis G virus (GBV-C/HGV) superinfection: elimination of resident viral strain by donor strain in a patient undergoing liver transplantation. J Med Virol, 68, 76–81.CrossRefGoogle Scholar
Farge, D., Lebbe, C., Marjanovic, Z., et al. (1999) Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Transplantation, 67, 1236–42.CrossRefGoogle ScholarPubMed
Frances, C., Monguet, C., Marcelin, A. G., et al. (2000) Outcome of kidney transplant recipients with previous human herpes virus 8 infection. Transplantation, 69 (9), 1776–9.CrossRefGoogle Scholar
Gao, S. J., Kingsley, L., Li, M., et al. (1996) KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med, 2, 925–8.CrossRefGoogle ScholarPubMed
George, S. L., Xiang, J. and Stapleton, J. T. (2003) Clinical isolates of GB virus type C vary in their ability to persist and replicate in peripheral blood mononuclear cell cultures. Virology, 316, 191–201.CrossRefGoogle ScholarPubMed
Gessain, A., Mauclere, P., Beveren, M., et al. (1999) Human herpes virus 8 primary infection occurs during childhood in Cameroon, Central Africa. Int J Cancer, 81, 189–92.3.0.CO;2-E>CrossRefGoogle ScholarPubMed
Halasz, R., Sallberg, M., Lundholm, S., et al. (2002) The GB virus C/hepatitis G virus replicates in hepatocytes without causing liver disease in healthy blood donors. J Infect Dis, 182, 1756–60.CrossRefGoogle Scholar
Heringlake, S., Osterkamp, S. and Trautwein, C. (1996) Association between fulminant hepatitis failure and a strain of GB virus C. Lancet, 348, 1626–9.CrossRefGoogle Scholar
Heuft, H. G., Berg, T., Schreier, E., et al. (1998) Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood. Vox Sang, 74, 161–7.CrossRefGoogle ScholarPubMed
Jenkins, F. J., Hoffman, L. J. and Liegey-Dougall, A. (2002) Reactivation of and primary infection with human herpes virus 8 among solid-organ transplant recipients. J Inf Dis, 185, 1238–43.CrossRefGoogle ScholarPubMed
Jones, D., Ballestas, M. E., Kaye, K. M., et al. (1998) Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient. N Eng J Med, 339, 444–8.CrossRefGoogle Scholar
Kakkola, L., Hedman, K., Vanrobaeys, H., et al. (2004) Cloning and sequencing of TT virus genotype 6 and expression of antigenic open reading frame 2 proteins. J Gen Virol, 83, 979–90.CrossRefGoogle Scholar
Karayiannis, P. and Thomas, H. C. (1997) Current status of hepatitis G virus (GBV-C) in transfusion: is it relevant?Vox Sang, 73, 63–9.CrossRefGoogle ScholarPubMed
Kojima, H., Kaita, K. D., Zhang, M., et al. (2003) Genomic analysis of a recently identified virus (SEN virus) and genotypes D and H by polymerase chain reaction. Antiviral Res, 60, 27–33.CrossRefGoogle Scholar
Lavreys, L., Chohan, B., Ashley, R., et al. (2002) Human herpes virus 8: seroprevalence and correlates in prostitutes in Mombasa, Kenya. J Inf Dis, 187, 359–63.CrossRefGoogle Scholar
Lefrere, J. J., Allain, J.-P., Prati, D., et al. (2003) West Nile virus and blood donors. Lancet, 361, 2083–4.CrossRefGoogle ScholarPubMed
Lefrere, J. J., Loiseau, P., Maury, J., et al. (1997) Natural history of GBV-C/ hepatitis G virus infection through the follow-up of GBV-C/hepatitis G virus-infected blood donors and recipients studied by RNA polymerase chain reaction and anti-E2 serology. Blood, 90, 3776–80.Google Scholar
Lefrere, J. J., Roudot-Thoraval, F., Lefrere, F., et al. (2000) Natural history of the TT virus infection through follow-up of TTV DNA-positive multiple-transfused patients. Blood, 95, 347–51.Google Scholar
Lefrere, J. J., Roudot-Thoraval, F., Morand-Joubert, L., et al. (1999a) Prevalence of GB virus type C/hepatitis G virus RNA and anti-E2 in individuals at high or low risk for blood-borne or sexually transmitted viruses: evidence of sexual and parenteral transmission. Transfusion, 39, 83–94.CrossRefGoogle Scholar
Lefrere, J. J., Roudot-Thoraval, F., Morand-Joubert, L., et al. (1999b) Carriage of GBV-C/hepatitis G virus RNA is associated with slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons. J Inf Dis, 179, 783–9.CrossRefGoogle Scholar
Lennette, E. T., Blackbourn, D. J. and Levy, J. A. (1996) Antibodies to human herpes virus type 8 in the general population and in Kaposi's sarcoma patients. Lancet, 348, 858–61.CrossRefGoogle ScholarPubMed
Lin, H. H., Kao, J. H., Lee, P. I., et al. (2002) Early acquisition of TT virus in infants: possible minor role of maternal transmission. J Med Virol, 66, 285–90.CrossRefGoogle ScholarPubMed
Lunel, F., Frangeul, L., Chuteau, C., et al. (1998) Transfusion-associated nosocomial hepatitis G virus infection in patients undergoing surgery. Transfusion, 38, 1097–103.CrossRefGoogle ScholarPubMed
Luppi, M., Barozzi, P., Schultz, T. F., et al. (2002a) Bone marrow failure associated with human herpes virus 8 infection after transplantation. N Eng J Med, 343, 1378–85.CrossRefGoogle Scholar
Luppi, M., Barozzi, P., Schultz, T. F., et al. (2002b) Nonmalignant disease associated with human herpes virus 8 reactivation in patients who have undergone autologous peripheral blood stem cell transplantation. Blood, 96, 2355–7.Google Scholar
Maggi, F., Pifferi, M., Fornai, C., et al. (2003) TT virus in the nasal secretions of children with acute respiratory diseases: relations to viremia and disease severity. J Virol, 77, 2418–25.CrossRefGoogle ScholarPubMed
Malnati, M., Broccolo, F., Nozza, S., et al. (2002) Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapy. Blood, 100, 1575–8.Google ScholarPubMed
Manni, F., Rotola, A., Caselli, E., et al. (2002) Detecting recombination in TT virus: a phylogenetic approach. J Mol Evol, 55, 563–72.CrossRefGoogle ScholarPubMed
Mantina, H., Kankasa, C., Klaskala, W., et al. (2001) Vertical transmission of Kaposi's sarcoma-associated herpes virus. Int J Cancer, 94, 749–52.CrossRefGoogle Scholar
Mbulaiteye, S. M., Pfeiffer, R. M., Whitby, D., et al. (2003) Human herpes virus 8 infection within families in rural Tanzania. J Inf Dis, 187, 1780–5.CrossRefGoogle ScholarPubMed
Meng, Y. X., Spira, T. J. and Bhat, G. J. (1999) Individuals from North America, Australasia, and Africa are infected with four different genotypes of human herpes virus 8. Virology, 261, 106–19.CrossRefGoogle Scholar
Mikuni, M., Moriyama, M., Tanaka, N., et al. (2002) SEN virus infection does not affect the progression of non-A to E liver disease. J Med Virol, 67, 624–9.CrossRefGoogle Scholar
Muerhoff, A. S., Simons, J. N., Leary, T. P., et al. (1996) Sequence heterogeneity within the 5-terminal region of the hepatitis GB virus C genome and evidence for genotypes. J Hepatol, 25, 379–84.CrossRefGoogle ScholarPubMed
Munoz, S. J., Alter, H. J., Nakatsuji, Y., et al. (1999) The significance of hepatitis G virus in serum of patients with sporadic fulminant and subfulminant hepatitis of unknown etiology. Blood, 94, 1460–4.Google ScholarPubMed
Mushawar, I. K., Erker, J. C., Muerhoff, A. S., et al. (1999) Molecular and biophysical characterization of TT virus: evidence for a new virus family infecting humans. Proc Ntl Acad Scie USA, 96, 3177–82.CrossRefGoogle Scholar
Nash, D., Mostashari, F., Fine, A., et al. (2001) The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med, 344, 1807–14.CrossRefGoogle ScholarPubMed
Ohto, H., Ujiie, N., Sato, A., et al. (2000) Mother-to-infant transmission of GB virus type C/HGV. Transfusion, 40, 725–30.CrossRefGoogle ScholarPubMed
Ohto, H., Ujiie, N., Takeuchi, C., et al. (2002) TT virus infection during childhood. Transfusion, 42, 892–8.CrossRefGoogle ScholarPubMed
Okamoto, H., Takahashi, M., Nishizawa, T., et al. (1999) Marked genomic heterogeneity and frequent mixed infection of TT virus demonstrated by PCR primers from coding and noncoding regions. Virology, 259, 428–36.CrossRefGoogle ScholarPubMed
Ott, C., Duret, L., Chemin, I., et al. (2000) Use of TT virus ORF1 recombinant protein to detect anti-TT virus antibodies in human sera. J Gen Virol, 81, 2949–58.CrossRefGoogle ScholarPubMed
Parravicini, C., Olsen, S. J., Capra, M., et al. (1997) Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian post-transplant Kaposi's sarcoma. Blood, 90, 2826–9.Google Scholar
Pirovano, S., Bellinzoni, M., Ballerini, C., et al. (2002) Transmission of SEN virus from mothers to their babies. J Med Virol, 66, 421–7.CrossRefGoogle ScholarPubMed
Pistello, M., Morrica, A., Maggi, F., et al. (2001) TT virus levels in the plasma of infected individuals with different hepatic and extrahepatic pathology. J Med Virol, 63, 189–95.3.0.CO;2-H>CrossRefGoogle ScholarPubMed
Regamey, N., Tamm, M., Wernli, M., et al. (1998) Transmission of human herpes virus 8 infection from renal transplant donors to recipients. N Engl J Med, 339, 1358–63.CrossRefGoogle ScholarPubMed
Renwick, N., Dukers, N. H. T. M., Weverling, G. J., et al. (2002) Risk factors for human herpes virus 8 infection in a cohort of drug users in the Netherlands, 1985–1996. J Inf Dis, 185, 1808–12.CrossRefGoogle Scholar
Rettig, M. B., Ma, H. J., Vescio, R. A., et al. (1997) Kaposi's sarcoma-associated herpes virus infection of bone marrow dendritic cells from multiple myeloma patients. Science, 276, 1851–4.CrossRefGoogle Scholar
Rigas, B., Hasan, I., Rehman, R., et al. (2001) Effect of treatment outcome of coinfection with SEN viruses in patients with hepatitis C. Lancet, 358, 1961–2.CrossRefGoogle ScholarPubMed
Saito, T., Matsumoto, S., Nojiri, O., et al. (1998) Multicyclic reverse transcription-polymerase chain reaction assay system for quantitation of GB virus-C/hepatitis G virus RNA in serum. J Virol Methods, 74, 185–91.CrossRefGoogle ScholarPubMed
Sentjens, R., Basaras, M., Simmonds, P., et al. (2003) HGV/GB virus C transmission by blood components in patients undergoing open-heart surgery. Transfusion, 43, 1558–62.CrossRefGoogle Scholar
Sheng, L., Soumillion, A., Peerlinck, K., et al. (1997) Hepatitis G viral RNA in serum and in peripheral blood mononuclear cells and its relation to HCV-RNA in patients with clotting disorders. Thromb Haemost, 77, 868–72.Google Scholar
Simmonds, P., Davidson, F., Lycet, C., et al. (1998) Detection of a novel DNA virus (TTV) in blood donors and blood products. Lancet, 352, 191–5.CrossRefGoogle ScholarPubMed
Simpson, G. R., Schulz, T. F., Whitby, D., et al. (1996) Prevalence of Kaposi's sarcoma associated herpes virus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet, 349, 1133–8.CrossRefGoogle Scholar
Spira, T. J., Lam, L., Dollard, S. C., et al. (2000) Comparison of serologic assays and PCR for diagnosis of human herpes virus 8 infection. J Clin Microbiol, 38, 2174–80.Google Scholar
Sugiyama, K., Goto, K., Ando, T., et al. (1999) Route of TT virus infection in children. J Med Virol, 59, 204–7.3.0.CO;2-T>CrossRefGoogle ScholarPubMed
Tangkijvanich, P., Theamboonlers, A., Sriponthong, M., et al. (2003) SEN virus infection and the risk of hepatocellular carcinoma: a case-control study. Am J Gastroenterol, 98, 2500–4.CrossRefGoogle ScholarPubMed
Tillmann, H. L., Heiken, H., Knapik-Botor, A., et al. (2001) Infection with GB virus C and reduced mortality among HIV infected patients. N Engl J Med, 345, 715–24.CrossRefGoogle Scholar
Tisdale, J. F., Stewart, A. K., Dickstein, B., et al. (1998) Molecular and serological examination of the relationship of human herpes virus 8 to multiple myeloma: orf 26 sequences in bone marrow stroma are not restricted to myeloma patients and other regions of the genome are not detected. Blood, 92, 2681–7.Google Scholar
Tsuda, F., Okamoto, H., Ukita, M., et al. (1999) Determination of antibodies to TT virus (TTV) and application to blood donors and patients with post-transfusion non-A to G hepatitis in Japan. J Virol Methods, 77, 199–206.CrossRefGoogle Scholar
Tsuda, F., Takahashi, M., Nishizawa, T., et al. (2001) IgM-class antibodies to TT virus (TTV) in patients with acute TTV infection. Hepatology Research, 19, 1–11.CrossRefGoogle Scholar
Umemura, T., Tanaka, Y., Kiyosawa, K., et al. (2002) Observation of positive selection within hypervariable regions of a newly identified DNA virus. FEBS Let, 510, 171–4.CrossRefGoogle ScholarPubMed
Umemura, T., Tanaka, E., Ostapowicz, G., et al. (2003) Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A–E hepatitis. J Infect Dis, 188, 1545–52.CrossRefGoogle ScholarPubMed
Umemura, T., Yeo, A. E. T., Sottini, A., et al. (2001) SEN virus infection and its relationship to transfusion-associated hepatitis. Hepatology, 33, 1303–11.CrossRefGoogle ScholarPubMed
Wong, S. G., Primi, D., Kojima, H., et al. (2002) Insights into SEN virus prevalence, transmission, and treatment in community-based persons and patients with liver disease referred to a liver disease unit. Clin Infect Dis, 35, 789–95.CrossRefGoogle ScholarPubMed
Worobey, M. and Holmes, E. C. (2001) Homologous recombination in GB virus C/hepatitis G virus. Mol Biol Evol, 18, 254–61.CrossRefGoogle ScholarPubMed
Xiang, J., Wunchmann, S., Diekema, D. J., et al. (2001) Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med, 345, 707–14.CrossRefGoogle Scholar
Yoshida, H., Kato, N., Shiratori, Y., et al. (2002) Weak association between SEN virus viremia and liver disease. J Clin Microbiol, 40, 3140–5.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Emerging viruses in transfusion
    • By Jean-Pierre Allain, Department of Haematology, The Division of Transfusion Medicine, Cambridge Blood Centre, Cambridge, UK, John A. J. Barbara, Emeritus Consultant in Microbiology to NHS Blood and Transplant and Visiting Professor in Transfusion Microbiology, University of the West of England, Bristol, UK
  • Edited by John A. J. Barbara, University of the West of England, Bristol, Fiona A. M. Regan, Marcela Contreras, University of the West of England, Bristol
  • Book: Transfusion Microbiology
  • Online publication: 12 January 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545245.010
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Emerging viruses in transfusion
    • By Jean-Pierre Allain, Department of Haematology, The Division of Transfusion Medicine, Cambridge Blood Centre, Cambridge, UK, John A. J. Barbara, Emeritus Consultant in Microbiology to NHS Blood and Transplant and Visiting Professor in Transfusion Microbiology, University of the West of England, Bristol, UK
  • Edited by John A. J. Barbara, University of the West of England, Bristol, Fiona A. M. Regan, Marcela Contreras, University of the West of England, Bristol
  • Book: Transfusion Microbiology
  • Online publication: 12 January 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545245.010
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Emerging viruses in transfusion
    • By Jean-Pierre Allain, Department of Haematology, The Division of Transfusion Medicine, Cambridge Blood Centre, Cambridge, UK, John A. J. Barbara, Emeritus Consultant in Microbiology to NHS Blood and Transplant and Visiting Professor in Transfusion Microbiology, University of the West of England, Bristol, UK
  • Edited by John A. J. Barbara, University of the West of England, Bristol, Fiona A. M. Regan, Marcela Contreras, University of the West of England, Bristol
  • Book: Transfusion Microbiology
  • Online publication: 12 January 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545245.010
Available formats
×